Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
30
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 52%
💰 Capital Raise
model 73%
• Critical: only 0.9 months cash remaining
• Active ATM program with $3M remaining capacity
🔄 Reverse Split
model est. 45%
• 50-day avg $1.15 approaching $1 threshold
• Only 1 months cash — financial pressure
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (68/100)
Market Data
Market Cap$4.53M
Shares Outstanding4.79M
Float3.79M
Cash$710.7K
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↓ 43.9% shares (2026Q1 vs prior)
12 institutional holders · 137.9K shares
#1
GEODE CAPITAL MANAGEMENT, LLC
45.7K shares
#2
MORGAN STANLEY
36.0K shares
#3
VANGUARD FIDUCIARY TRUST CO
21.0K shares
+ 9 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest236.4K
Days to Cover4.8
% of Float6.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-01-31
xbrl
XBRL CONVERTIBLE
2022-01-31
424B5
ATM
2026-03-06
8-K
8K EVENT
2026-03-06
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ALZN Dilution Snapshot
Alzamend Neuro, Inc. (ALZN) has a DilutionScore of 68/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $3.1M.
- Recent SEC activity tracked for ALZN: 424B5 on 2026-03-06; 8-K on 2026-03-06; xbrl on 2025-01-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: